BG
Bellevue Group Portfolio holdings
AUM
$4.81B
1-Year Est. Return
29.28%
1 Year Est. Return
+29.28%
AUM
$4.81B
AUM Growth
+$276M
(+6.1%)
Holding
159
Top Buys
| 1 | +$93.8M | |
| 2 | +$46.4M | |
| 3 | +$25.1M | |
| 4 |
Akero Therapeutics
AKRO
|
+$19.2M |
| 5 |
Immunocore
IMCR
|
+$12.9M |
Top Sells
| 1 | +$105M | |
| 2 | +$105M | |
| 3 | +$36.5M | |
| 4 |
Moderna
MRNA
|
+$31.8M |
| 5 |
Stryker
SYK
|
+$31M |
Sector Composition
| 1 | Healthcare | 99.85% |
| 2 | Technology | 0.03% |
| 3 | Consumer Discretionary | 0.02% |
| 4 | Communication Services | 0.02% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ionis Pharmaceuticals
IONS
$13.3B
| $409M | 8.49% |
6,244,451
-1,608,747
|
|
||
2
argenx
ARGX
$55.1B
| $403M | 8.37% |
546,328
-24,711
|
|
||
3
Revolution Medicines
RVMD
$14.7B
| $260M | 5.41% |
5,573,838
+994,538
|
|
||
4
Neurocrine Biosciences
NBIX
$15B
| $248M | 5.14% |
1,763,105
-56,895
|
|
||
5
Alnylam Pharmaceuticals
ALNY
$60.1B
| $204M | 4.23% |
446,524
-229,843
|
|
||
6
Vertex Pharmaceuticals
VRTX
$108B
| $198M | 4.12% |
505,805
+64,195
|
|
||
7
Abbott
ABT
$223B
| $198M | 4.11% |
1,478,563
-85,459
|
|
||
|
8
Stryker
SYK
$142B
| $167M | 3.46% |
451,096
-83,993
|
|
||
9
Boston Scientific
BSX
$150B
| $162M | 3.37% |
1,659,849
-105,345
|
|
||
10
Intuitive Surgical
ISRG
$201B
| $156M | 3.24% |
348,626
-30,102
|
|
||
11
Agios Pharmaceuticals
AGIO
$1.62B
| $149M | 3.1% |
3,714,736
+124,586
|
|
||
12
Incyte
INCY
$20B
| $122M | 2.54% |
1,440,686
-129,647
|
|
||
13
Scholar Rock
SRRK
$4.28B
| $121M | 2.51% |
3,244,537
+297,242
|
|
||
|
14
Akero Therapeutics
AKRO
$4.48B
| $113M | 2.36% |
2,389,314
+404,042
|
|
||
|
15
Immunocore
IMCR
$1.9B
| $102M | 2.11% |
2,796,803
+354,973
|
|
||
16
Avidity Biosciences
RNA
$10.8B
| $93.8M | 1.95% |
+2,152,862
|
|
||
17
Celldex Therapeutics
CLDX
$1.72B
| $92M | 1.91% |
3,557,669
+250,100
|
|
||
18
Medtronic
MDT
$132B
| $72.4M | 1.5% |
759,861
-161,182
|
|
||
19
Beam Therapeutics
BEAM
$2.44B
| $70.1M | 1.46% |
2,889,288
|
|
||
20
Edwards Lifesciences
EW
$49.5B
| $69.7M | 1.45% |
896,633
+7,556
|
|
||
21
Insulet
PODD
$21.9B
| $65.5M | 1.36% |
212,005
-7,008
|
|
||
22
UnitedHealth
UNH
$293B
| $58.7M | 1.22% |
170,057
+27,761
|
|
||
23
Becton Dickinson
BDX
$54.7B
| $55.6M | 1.15% |
296,894
-19,838
|
|
||
24
DexCom
DXCM
$24.8B
| $52.9M | 1.1% |
786,118
-74,710
|
|
||
25
Thermo Fisher Scientific
TMO
$220B
| $51.5M | 1.07% |
106,185
-7,359
|
|